These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 6377983)
21. Safety and efficacy of allergen immunotherapy in the treatment of allergic rhinitis and asthma in real life. Zeldin Y; Weiler Z; Magen E; Tiosano L; Kidon MI Isr Med Assoc J; 2008 Dec; 10(12):869-72. PubMed ID: 19160945 [TBL] [Abstract][Full Text] [Related]
22. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma. Kopp MV; Hamelmann E; Zielen S; Kamin W; Bergmann KC; Sieder C; Stenglein S; Seyfried S; Wahn U; Clin Exp Allergy; 2009 Feb; 39(2):271-9. PubMed ID: 19016798 [TBL] [Abstract][Full Text] [Related]
23. [Evaluation of the pediatric aspects of the WHO document and meta-analysis of immunotherapy]. Ibáñez Sendín MD Allergol Immunopathol (Madr); 2000; 28(3):82-9. PubMed ID: 10867375 [TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis. Frew AJ; Powell RJ; Corrigan CJ; Durham SR; J Allergy Clin Immunol; 2006 Feb; 117(2):319-25. PubMed ID: 16461133 [TBL] [Abstract][Full Text] [Related]
25. Sublingual immunotherapy with a standardised grass pollen extract; a double-blind placebo-controlled study. Hordijk GJ; Antvelink JB; Luwema RA Allergol Immunopathol (Madr); 1998; 26(5):234-40. PubMed ID: 9885731 [TBL] [Abstract][Full Text] [Related]
26. Double-blind, placebo-controlled study with a modified therapeutic vaccine of Salsola kali (Russian thistle) administered through use of a cluster schedule. Colás C; Monzón S; Venturini M; Lezaun A J Allergy Clin Immunol; 2006 Apr; 117(4):810-6. PubMed ID: 16630938 [TBL] [Abstract][Full Text] [Related]
27. The effects of allergen-specific immunotherapy on polymorphonuclear leukocyte functions in patients with seasonal allergic rhinitis. Soyoğul Gürer U; Büyüköztürk S; Palandüz S; Rayaman E; Colakoglu B; Cevikbaş A Int Immunopharmacol; 2005 Apr; 5(4):661-6. PubMed ID: 15710335 [TBL] [Abstract][Full Text] [Related]
28. Immunotherapy: first do no harm. Moss MH Immunol Allergy Clin North Am; 2005 May; 25(2):421-39, viii. PubMed ID: 15878464 [TBL] [Abstract][Full Text] [Related]
29. Significant decrease of IgE antibodies after a three-year controlled study of specific immunotherapy to pollen allergens in children with allergic asthma. Cantani A; Micera M Eur Rev Med Pharmacol Sci; 2005; 9(2):103-11. PubMed ID: 15945499 [TBL] [Abstract][Full Text] [Related]
30. Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood. Eng PA; Borer-Reinhold M; Heijnen IA; Gnehm HP Allergy; 2006 Feb; 61(2):198-201. PubMed ID: 16409196 [TBL] [Abstract][Full Text] [Related]
31. Cry j 1-induced synthesis of interleukin-5 and interferon-gamma by peripheral blood mononuclear cells of patients with seasonal allergic rhinitis due to Japanese cedar pollens. Nakai Y; Ohashi Y; Tanaka A; Kakinoki Y; Washio Y; Masamoto T; Yamada K; Nakai Y; Ohmoto Y Acta Otolaryngol Suppl; 1998; 538():143-51. PubMed ID: 9879414 [TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of subcutaneous immunotherapy with a biologically standardized extract of Ambrosia artemisiifolia pollen: a double-blind, placebo-controlled study. Mirone C; Albert F; Tosi A; Mocchetti F; Mosca S; Giorgino M; Pecora S; Parmiani S; Ortolani C Clin Exp Allergy; 2004 Sep; 34(9):1408-14. PubMed ID: 15347374 [TBL] [Abstract][Full Text] [Related]
33. Seasonal changes of proapoptotic soluble Fas ligand level in allergic rhinitis combined with asthma. Mezei G; Lévay M; Sepler Z; Héninger E; Kozma GT; Cserháti E Pediatr Allergy Immunol; 2006 Sep; 17(6):444-9. PubMed ID: 16925690 [TBL] [Abstract][Full Text] [Related]
34. Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC. Savolainen J; Jacobsen L; Valovirta E Allergy; 2006 Oct; 61(10):1184-90. PubMed ID: 16942566 [TBL] [Abstract][Full Text] [Related]
35. Omalizumab (Xolair) in children with seasonal allergic rhinitis: leukotriene release as a potential in vitro parameter to monitor therapeutic effects. Kopp MV; Stenglein S; Kamin W; Friedrichs F; von Berg A; Zielen S; Hamelmann E; Wahn U; Kuehr J Pediatr Allergy Immunol; 2007 Sep; 18(6):523-7. PubMed ID: 17680911 [TBL] [Abstract][Full Text] [Related]
36. [Rice pollen asthma and pollinosis in childhood: seasonal asthma and allergic rhinoconjunctivitis during the period of rice pollen emission in the surrouding area of rice field]. Yabuhara A; Shimojima K; Hokura M; Ishida T; Kawai H Arerugi; 2004 May; 53(5):494-501. PubMed ID: 15247529 [TBL] [Abstract][Full Text] [Related]
38. [Natural course from rhinitis to asthma in the patients with autumnal pollinosis: a clinical study of 1096 patients]. Yin J; Yue FM; Wang LL; He HJ; Xu T; Li H; Wen LP; Sun JL; Gu JQ; Han SM; Zhang HY; Ye ST Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(23):1628-32. PubMed ID: 16854304 [TBL] [Abstract][Full Text] [Related]
39. [Evaluation of soluble components of receptors with weak affinity for IgE (sCD23) in children with pollinosis given specific immunotherapy]. Boznański A; Willak-Janc E; Domanasiewicz M; Pirogowicz I; Widerska A Pneumonol Alergol Pol; 1996; 64(7-8):386-91. PubMed ID: 8983438 [TBL] [Abstract][Full Text] [Related]
40. [The immediate and long-term results of sylvinite speleoclimatotherapy in the children presenting with pollinosis]. Minaeva NV; Koriukina IP; Plakhina KV Vopr Kurortol Fizioter Lech Fiz Kult; 2014; (2):29-32. PubMed ID: 24864486 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]